Tribunal rules in favor of assessee, deems Commissioner's Section 263 invocation unjustified.

The Tribunal concluded that the Assessing Officer's order was not erroneous or prejudicial to the interest of revenue. It held that Medical Council of India regulations do not apply to pharmaceutical companies, and the CBDT Circular No. 5/2012 was not applicable to the assessment year in question. The Commissioner's invocation of Section 263 was deemed unjustified, and the appeal of the assessee was allowed. The advertisement and publicity expenses were considered legitimate business expenses, and the assessment order was upheld.

---

---

Issues Involved:
1. Whether the order passed by the Assessing Officer (AO) is erroneous and prejudicial to the interest of revenue.
2. Applicability of Medical Council of India (MCI) regulations to pharmaceutical companies.
3. Validity of invoking Section 263 by the Commissioner of Income Tax (CIT).
4. Nature and allowability of advertisement and publicity expenses under Section 37 of the Income Tax Act.
5. Applicability of CBDT Circular No. 5/2012 to the assessment year under consideration.

Issue-wise Detailed Analysis:

1. Whether the order passed by the AO is erroneous and prejudicial to the interest of revenue:
The CIT held that the AO's order was erroneous and prejudicial to the interest of revenue due to lack of proper enquiry and decision regarding the advertisement and publicity expenses incurred by the assessee. The AO did not call for the books of accounts or any corroborative evidence such as invoices or vouchers, nor did the assessee file any such details suo-motto.

2. Applicability of Medical Council of India (MCI) regulations to pharmaceutical companies:
The CIT rejected the assessee’s contention that MCI regulations are applicable only to medical practitioners and not to pharmaceutical companies. The assessee argued that the expenditure incurred was not in the nature of freebies to doctors and that MCI regulations apply only to doctors, not pharmaceutical companies. The Tribunal noted that the MCI regulations are applicable only to medical practitioners and not to pharmaceutical companies, and hence, the question of the assessee incurring expenditure in violation of these regulations does not arise.

3. Validity of invoking Section 263 by the CIT:
The assessee contended that the AO had called for and examined the details of the advertisement and publicity expenses during the assessment proceedings, and thus, the assessment order was neither erroneous nor prejudicial to the interest of revenue. The Tribunal observed that the AO had indeed called for the details and examined the nature of the expenditure before allowing it as a business expense. Therefore, the CIT’s invocation of Section 263 was not justified.

4. Nature and allowability of advertisement and publicity expenses under Section 37 of the Income Tax Act:
The assessee argued that the expenses incurred on advertisement and publicity were for creating awareness among doctors about its products and were essential for business promotion. The Tribunal agreed that such expenses were in the nature of sales and business promotion and should be allowed as business expenses. The Tribunal also noted that the gift articles and free samples provided by the assessee were for promoting its products and not freebies to doctors.

5. Applicability of CBDT Circular No. 5/2012 to the assessment year under consideration:
The assessee relied on the Tribunal’s decision in the case of Syncom Formulations (I) Ltd., where it was held that CBDT Circular No. 5/2012 was not applicable for assessment years prior to its introduction in A.Y. 2013-14. The Tribunal concurred that the circular was not applicable to the assessment year under consideration (A.Y. 2011-12) and thus could not be used to disallow the expenses.

Conclusion:
The Tribunal concluded that the AO had conducted a proper enquiry and examination of the expenses before allowing them as business expenses. The MCI regulations were not applicable to pharmaceutical companies, and the CBDT Circular No. 5/2012 did not apply to the relevant assessment year. Therefore, the CIT’s order invoking Section 263 was not justified, and the appeal of the assessee was allowed. The assessment order was neither erroneous nor prejudicial to the interest of revenue.

---